Terns Pharma Execs Load Up on Zero‑Cost Stock Amid 722% Share Surge, Betting on Pipeline Breakthroughs
Insider buying surge at Terns Pharmaceuticals: CMO, CFO, CEO lock in 356k shares and options, hinting at a bullish pipeline amid high volatility.
4 minutes to read